News

The MRDR recruits another hospital for the Myeloma 1000 Project.

MY-PROMPT-2 project randomises first patient and enrols another!

Ken Lim's paper on Inferior outcomes in t(11;14) multiple myeloma has been accepted for publication.

Congratulations on recruiting >6000 patients on the MRDR!!!

The MRDR supports Rare Disease Day 2023 😊

The MRDR has reached 5800 registered patients!

Paper on the second revision of the International Staging System (R2-ISS) accepted for publication!

The MRDR was recently represented at the 4th National Myeloma Workshop.

Thank you to all attendees for contributing to a successful MRDR Interest Group breakfast at Blood 2022!

The MRDR was well-represented at Blood 2022!